Natalia Pinilla-Echeverri

Natalia Pinilla-Echeverri

Auto-generated profile, based on publicly available information

Natalia Pinilla-Echeverri

McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2023 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Open access
NPNatalia Pinilla-Echeverri
Natalia Pinilla-Echeverri
MBMatthias Bossard
Matthias Bossard
AHAli Hillani
Ali Hillani
JCJorge A. Chavarria
Jorge A. Chavarria
GCGiacomo M. Cioffi
Giacomo M. Cioffi
TSTej Sheth
Tej Sheth
Calcified lesions often lead to difficulty achieving optimal stent expansion. OPN non-compliant (NC) is a twin layer balloon with high rated burst pressure that may modify calcium effectively. Retrospective, multicenter registry in patients undergoing optical coherence tomography (OCT) guided intervention with OPN NC. Superficial calcification with > 180o arc and > 0.5 mm thickness, and/or nodular calcification with > 90o arc were included. OCT was performed in all cases before and after OPN NC, and after intervention. Primary efficacy endpoints were frequency of expansion (EXP) ≥80 % of the mean reference lumen area and mean final EXP by OCT, and secondary endpoints were calcium fractures (CF), and EXP ≥90 %. 50 cases were included; 25 (50 %) superficial, and 25 (50 %) nodular. Calcium score of 4 in 42 (84 %) cases and 3 in 8 (16 %). OPN NC was used alone, or after other devices if further modification was needed, NC in 27 (54 %), cutting in 29 (58 %), scoring in 1 (2 %), IVL in 2 (4 %); or if non-crossable lesion, rotablation in 5 (10 %) cases. EXP ≥80 % was achieved in 40 (80 %) cases with mean final EXP post intervention of 85.7 % ± 8.9. CF were documented in 49 (98 %) cases; multiple in 37 (74 %). There were 1 flow limiting dissection requiring stent deployment and 3 non-cardiovascular related deaths in 6 months follow-up. No records of perforation, no-reflow or other major adverse events. Among patients with heavy calcified lesions undergoing OCT guided intervention with OPN NC, acceptable expansion was achieved in most cases without procedure related complications.

1 September 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
ZOZardasht Oqab
Zardasht Oqab
VKVijay Kunadian
Vijay Kunadian
DWDavid A. Wood
David A. Wood
RSRobert F. Storey
Robert F. Storey
SRSunil V. Rao
Sunil V. Rao
SMShamir R. Mehta
Shamir R. Mehta
BACKGROUND: In the COMPLETE trial (Complete Versus Culprit-Only Revascularization to Treat Multivessel Disease After Early PCI for STEMI), a strategy of complete revascularization reduced the risk of major cardiovascular events compared with culprit-lesion-only percutaneous coronary intervention in patients presenting with ST-segment–elevation myocardial infarction (STEMI) and multivessel coronary artery disease. Patients with diabetes have a worse prognosis following STEMI. We evaluated the consistency of the effects of complete revascularization in patients with and without diabetes. METHODS: The COMPLETE trial randomized a strategy of complete revascularization, consisting of angiography-guided percutaneous coronary intervention of all suitable nonculprit lesions, versus a strategy of culprit-lesion-only percutaneous coronary intervention (guideline-directed medical therapy alone). In prespecified analyses, treatment effects were determined in patients with and without diabetes on the first coprimary outcome of cardiovascular death or new myocardial infarction and the second coprimary outcome of cardiovascular death, new myocardial infarction, or ischemia-driven revascularization. Interaction P values were calculated to evaluate whether there was a differential treatment effect in patients with and without diabetes. RESULTS: Of the 4041 patients enrolled in the COMPLETE trial, 787 patients (19.5%) had diabetes. The median HbA1c (glycated hemoglobin) was 7.7% in the diabetes group and 5.7% in the nondiabetes group. Complete revascularization consistently reduced the first coprimary outcome in patients with diabetes (hazard ratio, 0.87 [95% CI, 0.59–1.29]) and without diabetes (hazard ratio, 0.70 [95% CI, 0.55–0.90]), with no evidence of a differential treatment effect (interaction P =0.36). Similarly, for the second coprimary outcome, no differential treatment effect (interaction P =0.27) of complete revascularization was found in patients with diabetes (hazard ratio, 0.61 [95% CI, 0.43–0.87]) and without diabetes (hazard ratio, 0.48 [95% CI, 0.39–0.60]). CONCLUSIONS: Among patients presenting with STEMI and multivessel disease, the benefit of complete revascularization over a culprit-lesion-only percutaneous coronary intervention strategy was consistent regardless of the presence or absence of diabetes.

7 January 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
MSMatthew Sibbald
Matthew Sibbald
HMHaley R. Mitchell
Haley R. Mitchell
JBJana Buccola
Jana Buccola
NPNatalia Pinilla-Echeverri
Natalia Pinilla-Echeverri
Integration of intravascular imaging into percutaneous coronary intervention (PCI) workflow demands physician time and expertise. Artificial intelligence (AI)-enabled software that automates the identification of key intravascular imaging parameters has the potential to streamline physician workflow, increase accuracy, and reduce variability in PCI planning decisions. This study investigated if AI-enabled software, Ultreon (Abbott), compared with traditional software, AptiVue (Abbott), improved physician decision-making accuracy, variability, and efficiency in optical coherence tomography (OCT)-based PCI planning. In this multireader, multicase study, 30 interventional cardiologists of varying OCT imaging experience evaluated 21 pre-PCI OCT pullbacks using both Ultreon and AptiVue platforms. Physician PCI planning decisions about lesion morphology, length, and diameter were compared to published best practices. Decision accuracy, variability, and time efficiency were assessed using statistical models. Physician OCT-based planning decisions were more accurate using Ultreon compared to AptiVue in the identification of calcium severity by 1.77 (95% CI, 1.27-2.50; P < .001), vessel preparation strategy by 2.00 (95% CI, 1.12-3.4; P = .018), and stent diameter by 2.83 (95% CI, 1.79-4.50; P < .001). Physicians exhibited less variability in assessments using Ultreon, especially for distal and proximal stent landing zone, and planned stent length (P < .0001). The efficiency of OCT assessments was improved with Ultreon, reducing the duration of OCT assessments by 0.5 minutes (P < .0001). The benefits were observed irrespective of the physician’s prior OCT experience. Physician OCT-based PCI planning decisions were more accurate, less variable, and more efficient with AI-enhanced Ultreon software. This could potentially aid in the fuller adoption of intravascular imaging in PCI workflow.

1 May 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
YSYader Sandoval
Yader Sandoval
JLJonathon A. Leipsic
Jonathon A. Leipsic
CCCarlos Collet
Carlos Collet
ZAZiad A. Ali
Ziad A. Ali
LALorenzo Azzalini
Lorenzo Azzalini
EBEmmanouil Brilakis
Emmanouil Brilakis
Coronary computed tomography angiography (CCTA) has emerged as an important tool for planning percutaneous coronary intervention (PCI). While it has traditionally been employed for diagnostic purposes, increasing evidence and real-world experience suggest that CCTA can be used for the preprocedural planning of PCI and can inform patient triage, shared decision making, case complexity, and resource use. This approach mirrors how computed tomography angiography is routinely used to plan structural interventions. To address these emerging opportunities, the Society for Cardiovascular Angiography & Interventions (SCAI) and the Society of Cardiovascular Computed Tomography (SCCT) organized a multidisciplinary, expert scientific roundtable on the use of CCTA for guiding PCI. The goal of this document is to provide a state-of-the-art overview of CCTA-guided PCI focused on practical applications and key coronary lesion subsets, define unmet needs and barriers, and outline future directions.

28 October 2025 in JACC
Verified
Journal Article
Closed access
SMShamir R. Mehta
Shamir R. Mehta
NPNatalia Pinilla-Echeverri
Natalia Pinilla-Echeverri
DTDenise Tiong
Denise Tiong
TKTanya Kovalova
Tanya Kovalova
TSTej Sheth
Tej Sheth
KBKevin R. Bainey
Kevin R. Bainey

22 May 2025 in JACC
Verified
Journal Article
Open access
TJThomas W. Johnson
Thomas W. Johnson
BBBrian A. Bergmark
Brian A. Bergmark
KCKevin Croce
Kevin Croce
DPDario Pellegrini
Dario Pellegrini
AMAkiko Maehara
Akiko Maehara
AJAllen Jeremias
Allen Jeremias
A novel optical coherence tomography (OCT)-based physiology assessment technique, virtual flow reserve (VFR), has been demonstrated to perform as a reliable surrogate for invasive physiology. We sought to examine the performance of post-PCI VFR as a predictor of 2-year clinical outcomes independent from the OCT-based minimal stent area (MSA). The ILUMIEN-IV trial prospectively recruited 2487 patients with diabetes or high-risk coronary lesions randomizing to OCT- versus angiography-guided drug-eluting stent implantation. All patients with single lesion treatment, who had a final OCT imaging available, underwent retrospective post-PCI VFR analysis offline. Of 2128 eligible patients, VFR analysis was successfully performed in 2057 (96.6%). Independent OCT predictors for the primary endpoint of 2-year target vessel failure (TVF), a composite of cardiac death, target-vessel myocardial infarction and ischemia-driven target vessel revascularization, were evaluated by multivariable analysis. The median [25th percentile, 75% percentile] post-PCI VFR was 0.90 [0.86, 0.92], with a significant difference in VFR observed between the angiography- and OCT-guided groups (0.89 [0.86, 0.92] vs 0.90 [0.87, 0.92], p<0.001). By multivariable analysis both MSA (per 1mm2) and VFR (per 0.1 mmHg/mmHg) were independent predictors of 2-year TVF. Overall, MSA, proximal edge dissection and VFR independently predicted both TVF and target lesion failure. Post-PCI OCT-based VFR assessment is predictive of 2-year clinical outcomes independent of MSA. Online VFR analysis can provide operators with an immediate assessment of post-PCI physiology in addition to OCT anatomy, providing incremental value in assessing procedural success and informing on clinical prognosis.